The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(Bis(4-methoxyphenyl)methylene)-N-(4-((6-methoxyquinolin-8-yl)amino)pentyl)hydrazinecarboxamide ID: ALA3330912
PubChem CID: 118713309
Max Phase: Preclinical
Molecular Formula: C31H35N5O4
Molecular Weight: 541.65
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: COc1ccc(C(=NNC(=O)NCCCC(C)Nc2cc(OC)cc3cccnc23)c2ccc(OC)cc2)cc1
Standard InChI: InChI=1S/C31H35N5O4/c1-21(34-28-20-27(40-4)19-24-8-6-17-32-30(24)28)7-5-18-33-31(37)36-35-29(22-9-13-25(38-2)14-10-22)23-11-15-26(39-3)16-12-23/h6,8-17,19-21,34H,5,7,18H2,1-4H3,(H2,33,36,37)
Standard InChI Key: VXHLPWUSNYOETR-UHFFFAOYSA-N
Molfile:
RDKit 2D
40 43 0 0 0 0 0 0 0 0999 V2000
15.3831 -8.8510 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1123 -9.2884 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1123 -10.0676 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4332 -10.5009 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7040 -10.1134 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7040 -9.2884 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9791 -10.5009 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9791 -11.3259 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7040 -11.7634 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4332 -11.3259 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.8415 -10.5009 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.5665 -10.0676 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5665 -9.2426 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.2498 -10.5009 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.9748 -10.0676 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7040 -10.5009 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4331 -10.0676 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.1123 -10.4550 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.8373 -10.0176 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.5665 -10.4550 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.2456 -10.0176 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.9247 -10.4550 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.9247 -11.2800 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.6539 -11.6676 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.3831 -11.2800 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.3831 -10.4550 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.6539 -10.0176 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.0622 -11.6676 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
26.7873 -11.2800 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.2456 -9.2426 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.9748 -8.8051 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.9748 -7.9801 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.2456 -7.5926 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.5164 -7.9801 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.5164 -8.8051 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.2456 -6.7677 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.5164 -6.3301 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.1123 -11.2800 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.3831 -8.0260 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.7040 -7.6384 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
1 6 1 0
5 7 1 0
8 7 2 0
9 8 1 0
10 9 2 0
4 10 1 0
3 11 1 0
12 11 1 0
13 12 1 0
12 14 1 0
14 15 1 0
15 16 1 0
16 17 1 0
17 18 1 0
18 19 1 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 22 1 0
25 28 1 0
28 29 1 0
21 30 1 0
30 31 2 0
31 32 1 0
32 33 2 0
33 34 1 0
34 35 2 0
35 30 1 0
33 36 1 0
36 37 1 0
18 38 2 0
1 39 1 0
39 40 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 541.65Molecular Weight (Monoisotopic): 541.2689AlogP: 5.59#Rotatable Bonds: 12Polar Surface Area: 106.10Molecular Species: NEUTRALHBA: 7HBD: 3#RO5 Violations: 2HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski): 2CX Acidic pKa: 11.70CX Basic pKa: 4.08CX LogP: 4.70CX LogD: 4.70Aromatic Rings: 4Heavy Atoms: 40QED Weighted: 0.12Np Likeness Score: -0.75
References 1. Pavić K, Perković I, Cindrić M, Pranjić M, Martin-Kleiner I, Kralj M, Schols D, Hadjipavlou-Litina D, Katsori AM, Zorc B.. (2014) Novel semicarbazides and ureas of primaquine with bulky aryl or hydroxyalkyl substituents: synthesis, cytostatic and antioxidative activity., 86 [PMID:25203780 ] [10.1016/j.ejmech.2014.09.013 ] 2. Levatić J, Pavić K, Perković I, Uzelac L, Ester K, Kralj M, Kaiser M, Rottmann M, Supek F, Zorc B.. (2018) Machine learning prioritizes synthesis of primaquine ureidoamides with high antimalarial activity and attenuated cytotoxicity., 146 [PMID:29407988 ] [10.1016/j.ejmech.2018.01.062 ] 3. Pavić K, Perković I, Pospíšilová Š, Machado M, Fontinha D, Prudêncio M, Jampilek J, Coffey A, Endersen L, Rimac H, Zorc B.. (2018) Primaquine hybrids as promising antimycobacterial and antimalarial agents., 143 [PMID:29220797 ] [10.1016/j.ejmech.2017.11.083 ]